1a6v:L     (GLN1) to   (THR107)  B1-8 FV FRAGMENT COMPLEXED WITH A (4-HYDROXY-3-NITROPHENYL) ACETATE COMPOUND  |   IMMUNOGLOBULIN, HAPTEN, IMMUNE SYSTEM 
3rpi:L     (GLN3) to    (LEU95)  CRYSTAL STRUCTURE OF FAB FROM 3BNC60, HIGHLY POTENT ANTI-HIV ANTIBODY  |   IGG, GLYCOSYLATION, IMMUNE SYSTEM 
3rpi:B     (GLN3) to    (LEU95)  CRYSTAL STRUCTURE OF FAB FROM 3BNC60, HIGHLY POTENT ANTI-HIV ANTIBODY  |   IGG, GLYCOSYLATION, IMMUNE SYSTEM 
1ahw:A     (ILE2) to   (ILE106)  A COMPLEX OF EXTRACELLULAR DOMAIN OF TISSUE FACTOR WITH AN INHIBITORY FAB (5G9)  |   BLOOD COAGULATION, TISSUE FACTOR, FAB, COMPLEX, ANTIBODY, COMPLEX (IMMUNOGLOBULIN/TISSUE FACTOR) 
1ahw:D     (ILE2) to   (ALA109)  A COMPLEX OF EXTRACELLULAR DOMAIN OF TISSUE FACTOR WITH AN INHIBITORY FAB (5G9)  |   BLOOD COAGULATION, TISSUE FACTOR, FAB, COMPLEX, ANTIBODY, COMPLEX (IMMUNOGLOBULIN/TISSUE FACTOR) 
1ar2:A     (ILE4) to   (ILE108)  DISULFIDE-FREE IMMUNOGLOBULIN FRAGMENT  |   DISULFIDE-FREE, IMMUNOGLOBULIN FRAGMENT, BENCE-JONES 
3eo0:A     (VAL3) to   (ILE107)  STRUCTURE OF THE TRANSFORMING GROWTH FACTOR-BETA NEUTRALIZING ANTIBODY GC-1008  |   CYTOKINE NEUTRALIZING ANTIBODY, FAB FRAGMENT, IMMUNE SYSTEM 
3eo0:C     (VAL3) to   (ILE107)  STRUCTURE OF THE TRANSFORMING GROWTH FACTOR-BETA NEUTRALIZING ANTIBODY GC-1008  |   CYTOKINE NEUTRALIZING ANTIBODY, FAB FRAGMENT, IMMUNE SYSTEM 
3eoa:A     (GLN3) to   (ILE106)  CRYSTAL STRUCTURE THE FAB FRAGMENT OF EFALIZUMAB IN COMPLEX WITH LFA-1 I DOMAIN, FORM I  |   EFALIZUMAB, FAB, ANTIBODY, LFA-1, CD11A, I DOMAIN, ALTERNATIVE SPLICING, CALCIUM, GLYCOPROTEIN, INTEGRIN, MAGNESIUM, MEMBRANE, POLYMORPHISM, RECEPTOR, TRANSMEMBRANE, IMMUNE SYSTEM/CELL ADHESION COMPLEX 
1axs:A     (LEU2) to   (ILE106)  MATURE OXY-COPE CATALYTIC ANTIBODY WITH HAPTEN  |   OXY-COPE, CATALYTIC ANTIBODY, FAB FRAGMENT 
1b0w:A     (ILE2) to   (ILE106)  STRUCTURAL COMPARISON OF AMYLOIDOGENIC LIGHT CHAIN DIMER IN TWO CRYSTAL FORMS WITH NONAMYLOIDOGENIC COUNTERPARTS  |   IMMUNOGLOBULIN, AMYLOID, IMMUNE SYSTEM 
1b0w:C     (ILE2) to   (ILE106)  STRUCTURAL COMPARISON OF AMYLOIDOGENIC LIGHT CHAIN DIMER IN TWO CRYSTAL FORMS WITH NONAMYLOIDOGENIC COUNTERPARTS  |   IMMUNOGLOBULIN, AMYLOID, IMMUNE SYSTEM 
2p8m:A     (LEU2) to   (VAL106)  CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ELLELDKWASLWN IN NEW CRYSTAL FORM  |   NMAB 2F5, HIV-1, GP41 EPITOPE, VIRAL PROTEIN 
4hh9:A     (VAL3) to   (ILE106)  ANTI-HUMAN CYTOMEGALOVIRUS (HCMV) FAB KE5  |   FAB, ANTIBODY, IMMUNE SYSTEM 
4hjj:L     (ILE2) to   (ILE106)  STRUCTURE REVEALS FUNCTION OF THE DUAL VARIABLE DOMAIN IMMUNOGLOBULIN (DVD-IG) MOLECULE  |   DFAB COMPLEX, IL-18, DUAL VARIABLE DOMAIN IMMUNOGLOBULIN, IMMUNE SYSTEM 
4x7t:B     (GLN3) to   (ILE110)  STRUCTURE OF OMALIZUMAB FAB FRAGMENT, CRYSTAL FORM 2  |   ANTIBODY FAB FRAGMENT, ANTI-IGE ANTIBODY, ANTI-INFLAMMATORY, IMMUNE SYSTEM 
1oak:L     (ILE2) to   (VAL106)  CRYSTAL STRUCTURE OF THE VON WILLEBRAND FACTOR (VWF) A1 DOMAIN IN COMPLEX WITH THE FUNCTION BLOCKING NMC-4 FAB  |   VON WILLEBRAND FACTOR, GLYCOPROTEIN IBA (A:ALPHA) BINDING, COMPLEX (WILLEBRAND/IMMUNOGLOBULIN), BLOOD COAGULATION 
4i2x:C     (ILE2) to   (ALA109)  CRYSTAL STRUCTURE OF SIGNAL REGULATORY PROTEIN GAMMA (SIRP-GAMMA) IN COMPLEX WITH FABOX117  |   PROTEIN-FAB COMPLEX, STRUCTURAL GENOMICS, OXFORD PROTEIN PRODUCTION FACILITY, OPPF, SIGNAL REGULATORY PROTEIN, CD47, CELL SURFACE, IMMUNE SYSTEM 
1cfn:A     (ILE2) to   (LEU106)  ANTI-P24 (HIV-1) FAB FRAGMENT CB41 COMPLEXED WITH AN EPITOPE-RELATED PEPTIDE  |   POLYSPECIFICITY, CROSS REACTIVITY, FAB-FRAGMENT, PEPTIDE, HIV-1 
1cft:A     (ILE2) to   (LEU106)  ANTI-P24 (HIV-1) FAB FRAGMENT CB41 COMPLEXED WITH AN EPITOPE-UNRELATED D-PEPTIDE  |   POLYSPECIFICITY, CROSS REACTIVITY, FAB-FRAGMENT, PEPTIDE, HIV-1 
2pw1:A     (LEU2) to   (VAL106)  CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ELDKWNSL  |   HIV-1, 2F5, GP41, NEUTRALIZING ANTIBODY, IMMUNE SYSTEM 
4ioi:A     (ASP1) to   (ILE106)  MEDITOPE-ENABLED TRASTUZUMAB IN COMPLEX WITH CQFDLSTRRLKC  |   MONOCLONAL ANTIBODY, IMMUNE SYSTEM, CANCER IMMUNOTHERAPY 
1dl7:L     (GLN1) to   (LEU109)  THE STRUCTURAL BASIS OF REPERTOIRE SHIFT IN AN IMMUNE RESPONSE TO PHOSPHOCHOLINE  |   SINGLE CHAIN FV, REPERTOIRE SHIFT, IMMUNE SYSTEM 
1dvf:A     (ASP1) to   (ILE106)  IDIOTOPIC ANTIBODY D1.3 FV FRAGMENT-ANTIIDIOTOPIC ANTIBODY E5.2 FV FRAGMENT COMPLEX  |   COMPLEX (IDIOTOPE-ANTIIDIOTOPE), IMMUNOGLOBULIN 
2r0k:L     (GLN3) to   (ILE106)  PROTEASE DOMAIN OF HGFA WITH INHIBITOR FAB58  |   SERINE PROTEASE, ANTIBODY, INHIBITOR, EGF-LIKE DOMAIN, GLYCOPROTEIN, HYDROLASE, KRINGLE, SECRETED, ZYMOGEN, IMMUNE SYSTEM 
2r0l:L     (ILE2) to   (THR109)  SHORT FORM HGFA WITH INHIBITORY FAB75  |   SERINE PROTEASE, ANTIBODY, ALLOSTERIC INHIBITOR, EGF-LIKE DOMAIN, GLYCOPROTEIN, HYDROLASE, KRINGLE, SECRETED, ZYMOGEN, IMMUNE SYSTEM 
2d7t:L     (ILE2) to   (ALA110)  CRYSTAL STRUCTURE OF HUMAN ANTI POLYHYDROXYBUTYRATE ANTIBODY FV  |   ANTIBODY, PLASTIC, POLYHYDROXYBUTYRATE, IMMUNE SYSTEM 
1qp1:A     (ILE2) to   (ILE106)  KAPPA VARIABLE LIGHT CHAIN  |   BETA SANDWICH, DOUBLE SPIRAL, IMMUNE SYSTEM 
4yk4:B     (GLN3) to   (THR109)  HUMAN ANTIBODY 641 I-9 IN COMPLEX WITH INFLUENZA HEMAGGLUTININ H1 SOLOMON ISLANDS/03/2006  |   INFLUENZA, ANTIBODY, COMPLEX, HEMAGGLUTININ, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
3u6r:L   (ALA150) to   (ILE253)  THREE DIMENSIONAL STRUCTURE OF BROADLY NEUTRALIZING ANTI - HEPATITIS C VIRUS (HCV) GLYCOPROTEIN E2 SINGLE CHAIN FV FRAGMENT 1:7  |   IG-LIKE DOMAIN, NEUTRALIZING SINGLE CHAIN FV, IMMUNE SYSTEM 
3u6r:B   (ALA150) to   (LYS254)  THREE DIMENSIONAL STRUCTURE OF BROADLY NEUTRALIZING ANTI - HEPATITIS C VIRUS (HCV) GLYCOPROTEIN E2 SINGLE CHAIN FV FRAGMENT 1:7  |   IG-LIKE DOMAIN, NEUTRALIZING SINGLE CHAIN FV, IMMUNE SYSTEM 
3u79:A     (GLN3) to   (ILE107)  AL-103 Y32F Y96F  |   IMMUNOGLOBULIN LIGHT CHAIN VARIABLE DOMAIN, IMMUNE SYSTEM 
3u79:C     (ASP1) to   (ILE107)  AL-103 Y32F Y96F  |   IMMUNOGLOBULIN LIGHT CHAIN VARIABLE DOMAIN, IMMUNE SYSTEM 
3u79:D     (ILE2) to   (ILE107)  AL-103 Y32F Y96F  |   IMMUNOGLOBULIN LIGHT CHAIN VARIABLE DOMAIN, IMMUNE SYSTEM 
3u79:G     (GLN3) to   (ILE107)  AL-103 Y32F Y96F  |   IMMUNOGLOBULIN LIGHT CHAIN VARIABLE DOMAIN, IMMUNE SYSTEM 
1fgn:L     (ILE2) to   (ILE106)  MONOCLONAL MURINE ANTIBODY 5G9-ANTI-HUMAN TISSUE FACTOR  |   ANTIBODY, FAB, ANTI-TF, MONOCLONAL, MURINE, IMMUNOGLOBULIN 
3uc0:L     (LEU3) to   (ILE107)  CRYSTAL STRUCTURE OF DOMAIN I OF THE ENVELOPE GLYCOPROTEIN ECTODOMAIN FROM DENGUE VIRUS SEROTYPE 4 IN COMPLEX WITH THE FAB FRAGMENT OF THE CHIMPANZEE MONOCLONAL ANTIBODY 5H2  |   DENGUE ANTIBODY MEMBRANE FUSION, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
3uc0:M     (LEU3) to   (ILE107)  CRYSTAL STRUCTURE OF DOMAIN I OF THE ENVELOPE GLYCOPROTEIN ECTODOMAIN FROM DENGUE VIRUS SEROTYPE 4 IN COMPLEX WITH THE FAB FRAGMENT OF THE CHIMPANZEE MONOCLONAL ANTIBODY 5H2  |   DENGUE ANTIBODY MEMBRANE FUSION, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
1fn4:C     (ASP1) to   (LEU106)  CRYSTAL STRUCTURE OF FAB198, AN EFFICIENT PROTECTOR OF ACETYLCHOLINE RECEPTOR AGAINST MYASTHENOGENIC ANTIBODIES  |   FAB198, IMMUNE SYSTEM 
1fvd:A     (ILE2) to   (ILE106)  X-RAY STRUCTURES OF THE ANTIGEN-BINDING DOMAINS FROM THREE VARIANTS OF HUMANIZED ANTI-P185-HER2 ANTIBODY 4D5 AND COMPARISON WITH MOLECULAR MODELING  |   IMMUNOGLOBULIN 
1fvd:C     (ILE2) to   (THR109)  X-RAY STRUCTURES OF THE ANTIGEN-BINDING DOMAINS FROM THREE VARIANTS OF HUMANIZED ANTI-P185-HER2 ANTIBODY 4D5 AND COMPARISON WITH MOLECULAR MODELING  |   IMMUNOGLOBULIN 
2fjf:C     (ASP1) to   (THR109)  STRUCTURE OF THE G6 FAB, A PHAGE DERIVED VEGF BINDING FAB  |   ANTIBODY, FAB, DODECAMER, IMMUNE SYSTEM 
2fjf:E     (GLN3) to   (THR109)  STRUCTURE OF THE G6 FAB, A PHAGE DERIVED VEGF BINDING FAB  |   ANTIBODY, FAB, DODECAMER, IMMUNE SYSTEM 
2fjh:A     (ILE2) to   (THR109)  STRUCTURE OF THE B20-4 FAB, A PHAGE DERIVED FAB FRAGMENT, IN COMPLEX WITH VEGF  |   VEGF, FAB, PROTEIN FAB COMPLEX, CYSTINE KNOT, HORMONE-GROWTH FACTOR- IMMUNE SYSTEM COMPLEX 
4z8f:L     (ASP1) to   (ALA109)  FAB STRUCTURE OF ANTIBODY S1-15 IN COMPLEX WITH SSDNA DNA, 5'-P5(DT)P- 3'  |   ANTIBODY, FAB, CARBOHYDRATE, LIPID A, DNA, IMMUNE SYSTEM-DNA COMPLEX 
2gcy:A     (VAL3) to   (THR113)  HUMANIZED ANTIBODY C25 FAB FRAGMENT  |   ANTIBODY FRAGMENT MOUSE HUMANIZED, IMMUNE SYSTEM 
2gfb:C     (ILE2) to   (ILE106)  CRYSTAL STRUCTURE OF A CATALYTIC FAB HAVING ESTERASE-LIKE ACTIVITY  |   IMMUNOGLOBULIN 
2gfb:M     (ILE2) to   (ILE106)  CRYSTAL STRUCTURE OF A CATALYTIC FAB HAVING ESTERASE-LIKE ACTIVITY  |   IMMUNOGLOBULIN 
2gfb:O     (ILE2) to   (ILE106)  CRYSTAL STRUCTURE OF A CATALYTIC FAB HAVING ESTERASE-LIKE ACTIVITY  |   IMMUNOGLOBULIN 
1t4k:A     (ASP1) to   (SER109)  CRYSTAL STRUCTURE OF UNLIGANDED ALDOLASE ANTIBODY 93F3 FAB  |   ENANTIOSELECTIVITY, ALDOLASE ANTIBODY, REACTIVE LYSINE, ALDOL REACTION, IMMUNE SYSTEM 
4l5f:L     (THR2) to   (ILE106)  CRYSTAL STRUCTURE OF DENV1-E106 FAB BOUND TO DENV-1 ENVELOPE PROTEIN DIII  |   ANTIBODY, FAB, NEUTRALIZING, VIRUS, ENVELOPE, VIRAL PROTEIN, IMMUNE SYSTEM, ANTIBODY EPITOPE, INFECTIOUS DISEASE, CENTER FOR STRUCTURAL GENOMICS OF INFECTIOUS DISEASES (CSGID), NIAID, NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES 
3idm:A     (ALA1) to   (VAL106)  CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 FAB' FRAGMENT IN COMPLEX WITH GP41 PEPTIDE ANALOG ELD(NRG)WAS  |   HIV-1, GP41, MPER, 2F5, IMMUNE SYSTEM 
1him:H     (VAL3) to   (LEU106)  STRUCTURAL EVIDENCE FOR INDUCED FIT AS A MECHANISM FOR ANTIBODY- ANTIGEN RECOGNITION  |   IMMUNOGLOBULIN 
1him:J     (VAL3) to   (LEU106)  STRUCTURAL EVIDENCE FOR INDUCED FIT AS A MECHANISM FOR ANTIBODY- ANTIGEN RECOGNITION  |   IMMUNOGLOBULIN 
2hff:A     (ILE2) to   (ILE106)  CRYSTAL STRUCTURE OF CB2 FAB  |   FAB FRAGMENT, PHAGE LIBRARIES, COMBINATORIAL SELECTION, IMMUNE SYSTEM 
5a16:H     (ASP1) to   (ILE110)  CRYSTAL STRUCTURE OF FAB4201 RAISED AGAINST HUMAN ERYTHROCYTE ANION EXCHANGER 1  |   IMMUNE SYSTEM, FAB FRAGMENT, ANION EXCHANGER 
1i8k:A     (GLU3) to   (ILE106)  CRYSTAL STRUCTURE OF DSFV MR1 IN COMPLEX WITH THE PEPTIDE ANTIGEN OF THE MUTANT EPIDERMAL GROWTH FACTOR RECEPTOR, EGFRVIII, AT LIQUID NITROGEN TEMPERATURE  |   ANTIBODY-PEPTIDE COMPLEX, IMMUNOGLOBULIN FOLD, PEPTIDE ANTIGEN, TYPE II' BETA TURN., IMMUNE SYSTEM 
1ifh:L     (VAL3) to   (LEU106)  A DETAILED ANALYSIS OF THE FREE AND BOUND CONFORMATION OF AN ANTIBODY: X-RAY STRUCTURES OF ANTI-PEPTIDE FAB 17(SLASH)9 AND THREE DIFFERENT FAB-PEPTIDE COMPLEXES  |   IMMUNOGLOBULIN 
1um6:L     (ILE4) to   (THR111)  CATALYTIC ANTIBODY 21H3  |   CATALYTIC ANTIBODY LIGAND TRANSESTERIFICATION, IMMUNE SYSTEM 
4m6o:L     (ALA1) to   (ILE106)  CRYSTAL STRUCTURE OF ANTI-NGF ANTIBODY CNTO7309  |   IMMUNOGLOBULIN FOLD, ANTIBODY, IMMUNE SYSTEM 
4mau:L     (ASP1) to   (ILE110)  CRYSTAL STRUCTURE OF ANTI-ST2L ANTIBODY C2244  |   IMMUNOGLOBULIN FOLD, ANTIBODY, IMMUNE SYSTEM 
1jnh:G     (ALA2) to   (VAL108)  CRYSTAL STRUCTURE OF FAB-ESTRADIOL COMPLEXES  |   IGG FOLD, ANTIBODY-HAPTEN COMPLEX, ESTRADIOL, IMMUNE SYSTEM 
1jps:L     (GLN3) to   (THR109)  CRYSTAL STRUCTURE OF TISSUE FACTOR IN COMPLEX WITH HUMANIZED FAB D3H44  |   ANTIGEN-ANTIBODY RECOGNITION, HUMANIZED ANTIBODY, BLOOD COAGULATION, INTERFACE WATER MOLECULES, CRYSTAL STRUCTURE, IMMUNE SYSTEM 
2xkn:C     (ASP1) to   (ILE106)  CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF THE ANTI-EGFR ANTIBODY 7A7  |   IMMUNE SYSTEM, IMMUNOGLOBULIN 
2xra:L     (ILE2) to   (ARG108)  CRYSTAL STRUCTURE OF THE HK20 FAB IN COMPLEX WITH A GP41 MIMETIC 5-HELIX  |   IMMUNE SYSTEM, ANTIBODY, MONOCLONAL CELLS, NEUTRALIZATION TESTS 
5bo1:L     (ASP1) to   (THR109)  CRYSTAL STRUCTURE OF A HUMAN JAG1 FRAGMENT IN COMPLEX WITH AN ANTI- JAG1 FAB  |   JAG, NOTCH, ANTAGONIST, SIGNALING PROTEIN-IMMUNE SYSTEM COMPLEX 
1wtl:A     (ILE2) to   (ILE106)  COMPARISON OF CRYSTAL STRUCTURES OF TWO HOMOLOGOUS PROTEINS: STRUCTURAL ORIGIN OF ALTERED DOMAIN INTERACTIONS IN IMMUNOGLOBULIN LIGHT CHAIN DIMERS  |   IMMUNOGLOBULIN 
4nnp:L     (ILE2) to   (THR110)  CRYSTAL STRUCTURE OF APO MANGANESE ABC TRANSPORTER MNTC FROM STAPHYLOCOCCUS AUREUS BOUND TO AN ANTAGONISTIC FAB FRAGMENT  |   ABC SUPERFAMILY ATP BINDING CASSETTE TRANSPORTER, MNTC, FAB, APO, MRSA, TRANSPORT PROTEIN-IMMUNE SYSTEM COMPLEX 
4nnp:Y     (ILE2) to   (ILE107)  CRYSTAL STRUCTURE OF APO MANGANESE ABC TRANSPORTER MNTC FROM STAPHYLOCOCCUS AUREUS BOUND TO AN ANTAGONISTIC FAB FRAGMENT  |   ABC SUPERFAMILY ATP BINDING CASSETTE TRANSPORTER, MNTC, FAB, APO, MRSA, TRANSPORT PROTEIN-IMMUNE SYSTEM COMPLEX 
4o4y:L     (PCA1) to   (ARG114)  CRYSTAL STRUCTURE OF THE ANTI-HINGE RABBIT ANTIBODY 2095-2 IN COMPLEX WITH IDES HINGE PEPTIDE  |   IMMUNOGLOBULIN FOLD, ANTIBODY, HINGE, IMMUNE SYSTEM 
4odu:L     (ASP1) to   (ALA109)  UNLIGANDED FAB STRUCTURE OF LIPID A-SPECIFIC ANTIBODY S1-15  |   CARBOHYDRATE BINDING, IMMUNE SYSTEM 
4odu:B     (ILE2) to   (ILE106)  UNLIGANDED FAB STRUCTURE OF LIPID A-SPECIFIC ANTIBODY S1-15  |   CARBOHYDRATE BINDING, IMMUNE SYSTEM 
1lk3:M     (THR2) to   (ALA108)  ENGINEERED HUMAN INTERLEUKIN-10 MONOMER COMPLEXED TO 9D7 FAB FRAGMENT  |   ANTIGEN-ANTIBODY COMPLEX, IMMUNE SYSTEM 
1y0l:A     (LEU2) to   (ILE106)  CATALYTIC ELIMINATION ANTIBODY 34E4 IN COMPLEX WITH HAPTEN  |   IMMUNOGLOBULIN, CATALYTIC ANTIBODY, CHIMERIC FAB, HAPTEN COMPLEX, IMMUNE SYSTEM 
1y0l:C     (LEU2) to   (ILE106)  CATALYTIC ELIMINATION ANTIBODY 34E4 IN COMPLEX WITH HAPTEN  |   IMMUNOGLOBULIN, CATALYTIC ANTIBODY, CHIMERIC FAB, HAPTEN COMPLEX, IMMUNE SYSTEM 
1y0l:E     (LEU2) to   (ILE106)  CATALYTIC ELIMINATION ANTIBODY 34E4 IN COMPLEX WITH HAPTEN  |   IMMUNOGLOBULIN, CATALYTIC ANTIBODY, CHIMERIC FAB, HAPTEN COMPLEX, IMMUNE SYSTEM 
1mex:L     (ASP1) to   (ALA109)  ANTIBODY CATALYSIS OF A BIMOLECULAR CYCLOADDITION REACTION  |   IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM 
1mhh:A     (VAL3) to   (ALA109)  ANTIBODY-ANTIGEN COMPLEX  |   ANTIBODY-ANTIGEN COMPLEX, B CELL SUPERANTIGEN, IMMUNOGLOBULIN BINDING PROTEIN, IMMUNE SYSTEM 
1mhh:C     (ILE2) to   (LEU106)  ANTIBODY-ANTIGEN COMPLEX  |   ANTIBODY-ANTIGEN COMPLEX, B CELL SUPERANTIGEN, IMMUNOGLOBULIN BINDING PROTEIN, IMMUNE SYSTEM 
1moe:A     (ILE2) to   (ILE110)  THE THREE-DIMENSIONAL STRUCTURE OF AN ENGINEERED SCFV T84.66 DIMER OR DIABODY IN VL TO VH LINKAGE.  |   ANTI CARCINOEMBRYONIC ANTIGEN, T84.66, DIABODY, DIMER, SCFV, VARIABLE DOMAIN, IMMUNE SYSTEM 
1mvu:A     (ASP1) to   (PRO112)  SINGLE CHAIN FV OF C219 HEAVY CHAIN V101L MUTANT IN COMPLEX WITH SYNTHETIC EPITOPE PEPTIDE  |   SINGLE CHAIN FV, MONOCLONAL ANTIBODY, C219, P-GLYCOPROTEIN, IMMUNOGLOBULIN, SITE-DIRECTED MUTAGENESIS, IMMUNE SYSTEM 
5d96:I     (ASP1) to   (LEU106)  OXIDOREDUCTASE FRAGMENT OF MOUSE QSOX1 IN COMPLEX WITH A FAB FRAGMENT FROM AN ANTIBODY TARGETING MOUSE AND HUMAN QSOX1  |   ENZYME, INHIBITOR, ANTIBODY, DUAL-SPECIFICITY, IMMUNE SYSTEM 
5d96:B     (ASP1) to   (LEU106)  OXIDOREDUCTASE FRAGMENT OF MOUSE QSOX1 IN COMPLEX WITH A FAB FRAGMENT FROM AN ANTIBODY TARGETING MOUSE AND HUMAN QSOX1  |   ENZYME, INHIBITOR, ANTIBODY, DUAL-SPECIFICITY, IMMUNE SYSTEM 
5dhv:B     (LEU2) to   (ILE109)  HIV-1 REV NTD DIMERS WITH VARIABLE CROSSING ANGLES  |   HIV, HELICAL HAIRPIN, RNA-BINDING, NUCLEAR EXPORT, IMMUNE SYSTEM 
5dhv:L     (LEU2) to   (ILE109)  HIV-1 REV NTD DIMERS WITH VARIABLE CROSSING ANGLES  |   HIV, HELICAL HAIRPIN, RNA-BINDING, NUCLEAR EXPORT, IMMUNE SYSTEM 
5dhx:B     (LEU2) to   (ILE109)  HIV-1 REV NTD DIMERS WITH VARIABLE CROSSING ANGLES  |   HIV, HELICAL HAIRPIN, RNA-BINDING, NUCLEAR EXPORT, IMMUNE SYSTEM 
5dhx:L     (LEU2) to   (ILE109)  HIV-1 REV NTD DIMERS WITH VARIABLE CROSSING ANGLES  |   HIV, HELICAL HAIRPIN, RNA-BINDING, NUCLEAR EXPORT, IMMUNE SYSTEM 
5dhy:B     (LEU2) to   (ILE110)  HIV-1 REV NTD DIMERS WITH VARIABLE CROSSING ANGLES  |   HIV, HELICAL HAIRPIN, RNA-BINDING, NUCLEAR EXPORT, IMMUNE SYSTEM 
5dhy:L     (LEU2) to   (ILE110)  HIV-1 REV NTD DIMERS WITH VARIABLE CROSSING ANGLES  |   HIV, HELICAL HAIRPIN, RNA-BINDING, NUCLEAR EXPORT, IMMUNE SYSTEM 
5dhz:L     (LEU2) to   (ILE109)  HIV-1 REV NTD DIMERS WITH VARIABLE CROSSING ANGLES  |   HIV, HELICAL HAIRPIN, NUCLEAR EXPORT, RNA-BINDING, IMMUNE SYSTEM 
1n64:L     (ILE2) to   (ALA109)  CRYSTAL STRUCTURE ANALYSIS OF THE IMMUNODOMINANT ANTIGENIC SITE ON HEPATITIS C VIRUS PROTEIN BOUND TO MAB 19D9D6  |   ANTIBODY PEPTIDE COMPLEX, IMMUNE SYSTEM 
3l7f:L     (VAL3) to   (ILE106)  STRUCTURE OF IL-13 ANTIBODY H2L6, A HUMANIZED VARIANT OF C836  |   IMMUNOGLOBULIN FOLD, MONOCLONAL ANTIBODY, IMMUNE SYSTEM 
3l7f:A     (GLU1) to   (ILE106)  STRUCTURE OF IL-13 ANTIBODY H2L6, A HUMANIZED VARIANT OF C836  |   IMMUNOGLOBULIN FOLD, MONOCLONAL ANTIBODY, IMMUNE SYSTEM 
3l7f:D     (VAL3) to   (THR109)  STRUCTURE OF IL-13 ANTIBODY H2L6, A HUMANIZED VARIANT OF C836  |   IMMUNOGLOBULIN FOLD, MONOCLONAL ANTIBODY, IMMUNE SYSTEM 
5dmg:L   (VAL503) to   (VAL809)  X-RAY STRUCTURE OF THE FAB FRAGMENT OF THE ANTI TAU ANTIBODY RB86 IN COMPLEX WITH THE PHOSPHORYLATED TAU PEPTIDE (416-430)  |   ANTIBODY, FAB FRAGMENT, TAU PROTEIN, TAU-PSER422, TAU-PSER422 COMPLEX, IMMUNE SYSTEM 
5dmg:D   (VAL503) to   (VAL809)  X-RAY STRUCTURE OF THE FAB FRAGMENT OF THE ANTI TAU ANTIBODY RB86 IN COMPLEX WITH THE PHOSPHORYLATED TAU PEPTIDE (416-430)  |   ANTIBODY, FAB FRAGMENT, TAU PROTEIN, TAU-PSER422, TAU-PSER422 COMPLEX, IMMUNE SYSTEM 
5do2:D     (ASP1) to   (ILE106)  COMPLEX STRUCTURE OF MERS-RBD BOUND WITH 4C2 ANTIBODY  |   RECEPTOR-BINDING DOMAIN OF MERS-COV SPIKE, 4C2 ANTIBODY, NEURALIZATION, RECEPTOR-BINDING BLOCKING., VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
2adi:A     (THR2) to   (ILE106)  CRYSTAL STRUCTURE OF MONOCLONAL ANTI-CD4 ANTIBODY Q425 IN COMPLEX WITH BARIUM  |   ANTI-CD4, INTERFACIAL METAL, ANTIBODY RECOGNITION, IMMUNE SYSTEM 
3b9k:L     (ILE2) to   (LEU106)  CRYSTAL STRUCTURE OF CD8ALPHA-BETA IN COMPLEX WITH YTS 156.7 FAB  |   IMMUNOGLOBULIN DOMAIN, V-SET, IGSF DIMER, GLYCOPROTEIN, IMMUNE RESPONSE, MEMBRANE, TRANSMEMBRANE, IMMUNE SYSTEM 
3mod:L     (ALA1) to   (VAL106)  CRYSTAL STRUCTURE OF THE NEUTRALIZING HIV ANTIBODY 2F5 FAB FRAGMENT (RECOMBINANTLY PRODUCED IGG) WITH 11 AA GP41 MPER-DERIVED PEPTIDE  |   HIV-1, HIV GP41 MPER, 13H11, 2F5, Z13, 4E10, FAB ANTIBODY, IMMUNE SYSTEM 
4qy8:B     (ASP1) to   (ILE110)  CRYSTAL STRUCTURE OF ANTI-MSP2 FV FRAGMENT (MAB6D8) IN COMPLEX WITH 3D7-MSP2 14-30  |   IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM, N-TERMINAL MSP2, UNSTRUCTURED ANTIGEN 
5f7e:L     (ILE2) to   (ILE102)  CRYSTAL STRUCTURE OF GERM-LINE PRECURSOR OF 3BNC60 FAB  |   ANTIBODY, IMMUNE SYSTEM, HIV-1 
3n85:L     (ASP1) to   (THR109)  CRYSTALLOGRAPHIC TRIMER OF HER2 EXTRACELLULAR REGIONS IN COMPLEX WITH TRYPTOPHAN-RICH ANTIBODY FRAGMENT  |   HER2, ERBB2, TRP/SER LIBRARY, PHAGE DISPLAY, TRANSFERASE-IMMUNE SYSTEM COMPLEX 
4bz2:L     (LYS3) to   (LEU106)  STRUCTURE OF DENGUE VIRUS EDIII IN COMPLEX WITH FAB 2D73  |   IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX, IMMUNE SYSTEM, ANTIBODY, IMMUNOGLOBULIN, FUSION LOOP, VIRION 
4r96:A     (VAL3) to   (THR115)  STRUCTURE OF A LLAMA GLAMA FAB 48A2 AGAINST HUMAN CMET  |   IMMUNOGLOBULIN DOMAINS, IMMUNE SYSTEM, CMET 
4r96:C     (VAL3) to   (ILE112)  STRUCTURE OF A LLAMA GLAMA FAB 48A2 AGAINST HUMAN CMET  |   IMMUNOGLOBULIN DOMAINS, IMMUNE SYSTEM, CMET 
4r96:E     (ASP1) to   (ILE112)  STRUCTURE OF A LLAMA GLAMA FAB 48A2 AGAINST HUMAN CMET  |   IMMUNOGLOBULIN DOMAINS, IMMUNE SYSTEM, CMET 
4r96:L     (ASP1) to   (ILE112)  STRUCTURE OF A LLAMA GLAMA FAB 48A2 AGAINST HUMAN CMET  |   IMMUNOGLOBULIN DOMAINS, IMMUNE SYSTEM, CMET 
3cdy:A     (ILE2) to   (ILE106)  AL-09 H87Y, IMMUNOGLOBULIN LIGHT CHAIN VARIABLE DOMAIN  |   GREEK KEY BETA BARREL, IMMUNOGLOBULIN, LIGHT CHAIN, VARIABLE DOMAIN, AMYLOIDOSIS, IMMUNE SYSTEM 
3cfk:L     (LEU2) to   (ILE106)  CRYSTAL STRUCTURE OF CATALYTIC ELIMINATION ANTIBODY 34E4, TRICLINIC CRYSTAL FORM  |   IMMUNOGLOBULIN, CATALYTIC ANTIBODY, CHIMERIC FAB, APO FORM, PROTON TRANSFER, CONFORMATIONAL CHANGE, IMMUNE SYSTEM, CHIMERA, IMMUNOGLOBULIN DOMAIN, IMMUNOGLOBULIN V REGION 
3cfk:A     (LEU2) to   (ILE106)  CRYSTAL STRUCTURE OF CATALYTIC ELIMINATION ANTIBODY 34E4, TRICLINIC CRYSTAL FORM  |   IMMUNOGLOBULIN, CATALYTIC ANTIBODY, CHIMERIC FAB, APO FORM, PROTON TRANSFER, CONFORMATIONAL CHANGE, IMMUNE SYSTEM, CHIMERA, IMMUNOGLOBULIN DOMAIN, IMMUNOGLOBULIN V REGION 
3cfk:C     (LEU2) to   (ILE106)  CRYSTAL STRUCTURE OF CATALYTIC ELIMINATION ANTIBODY 34E4, TRICLINIC CRYSTAL FORM  |   IMMUNOGLOBULIN, CATALYTIC ANTIBODY, CHIMERIC FAB, APO FORM, PROTON TRANSFER, CONFORMATIONAL CHANGE, IMMUNE SYSTEM, CHIMERA, IMMUNOGLOBULIN DOMAIN, IMMUNOGLOBULIN V REGION 
3cfk:E     (LEU2) to   (ILE106)  CRYSTAL STRUCTURE OF CATALYTIC ELIMINATION ANTIBODY 34E4, TRICLINIC CRYSTAL FORM  |   IMMUNOGLOBULIN, CATALYTIC ANTIBODY, CHIMERIC FAB, APO FORM, PROTON TRANSFER, CONFORMATIONAL CHANGE, IMMUNE SYSTEM, CHIMERA, IMMUNOGLOBULIN DOMAIN, IMMUNOGLOBULIN V REGION 
3cfk:G     (LEU2) to   (ILE106)  CRYSTAL STRUCTURE OF CATALYTIC ELIMINATION ANTIBODY 34E4, TRICLINIC CRYSTAL FORM  |   IMMUNOGLOBULIN, CATALYTIC ANTIBODY, CHIMERIC FAB, APO FORM, PROTON TRANSFER, CONFORMATIONAL CHANGE, IMMUNE SYSTEM, CHIMERA, IMMUNOGLOBULIN DOMAIN, IMMUNOGLOBULIN V REGION 
3cfk:J     (LEU2) to   (ILE106)  CRYSTAL STRUCTURE OF CATALYTIC ELIMINATION ANTIBODY 34E4, TRICLINIC CRYSTAL FORM  |   IMMUNOGLOBULIN, CATALYTIC ANTIBODY, CHIMERIC FAB, APO FORM, PROTON TRANSFER, CONFORMATIONAL CHANGE, IMMUNE SYSTEM, CHIMERA, IMMUNOGLOBULIN DOMAIN, IMMUNOGLOBULIN V REGION 
3cfk:M     (LEU2) to   (ILE106)  CRYSTAL STRUCTURE OF CATALYTIC ELIMINATION ANTIBODY 34E4, TRICLINIC CRYSTAL FORM  |   IMMUNOGLOBULIN, CATALYTIC ANTIBODY, CHIMERIC FAB, APO FORM, PROTON TRANSFER, CONFORMATIONAL CHANGE, IMMUNE SYSTEM, CHIMERA, IMMUNOGLOBULIN DOMAIN, IMMUNOGLOBULIN V REGION 
3cfk:O     (LEU2) to   (ILE106)  CRYSTAL STRUCTURE OF CATALYTIC ELIMINATION ANTIBODY 34E4, TRICLINIC CRYSTAL FORM  |   IMMUNOGLOBULIN, CATALYTIC ANTIBODY, CHIMERIC FAB, APO FORM, PROTON TRANSFER, CONFORMATIONAL CHANGE, IMMUNE SYSTEM, CHIMERA, IMMUNOGLOBULIN DOMAIN, IMMUNOGLOBULIN V REGION 
3cmo:L     (ASP1) to   (ILE106)  HIV NEUTRALIZING MONOCLONAL ANTIBODY YZ18  |   HIV-1, MONOCLONAL ANTIBODY, IMMUNE SYSTEM 
3csy:B     (GLU1) to   (ILE106)  CRYSTAL STRUCTURE OF THE TRIMERIC PREFUSION EBOLA VIRUS GLYCOPROTEIN IN COMPLEX WITH A NEUTRALIZING ANTIBODY FROM A HUMAN SURVIVOR  |   GLYCOPROTEIN-ANTIBODY COMPLEX, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX 
3cvh:L     (ILE1) to   (LEU105)  HOW TCR-LIKE ANTIBODY RECOGNIZES MHC-BOUND PEPTIDE  |   MHC, TCR, GLYCOPROTEIN, IMMUNE RESPONSE, MEMBRANE, MHC I, TRANSMEMBRANE, ALLERGEN, PHOSPHOPROTEIN, SECRETED, IMMUNOGLOBULIN DOMAIN, IMMUNE SYSTEM 
3o45:L     (ILE2) to   (ALA109)  CRYSTAL STRUCTURE OF 101F FAB BOUND TO 17-MER PEPTIDE EPITOPE  |   IMMUNOGLOBULIN, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX 
3d0v:A     (LEU2) to   (VAL106)  CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE LLELDKWASLW  |   2F5, HIV, GP41, ANTIBODY, NEUTRALIZING, IMMUNE SYSTEM 
4s1d:L     (GLN3) to   (ILE106)  STRUCTURE OF IGG1 FAB FRAGMENT IN COMPLEX WITH BIOTINCYTIDINAMIDE  |   ANTIBODY, FAB FRAGMENT, HAPTEN, MAB_M33_FAB_FRAGMENT, IMMUNE SYSTEM 
4s1d:D     (GLN3) to   (ALA109)  STRUCTURE OF IGG1 FAB FRAGMENT IN COMPLEX WITH BIOTINCYTIDINAMIDE  |   ANTIBODY, FAB FRAGMENT, HAPTEN, MAB_M33_FAB_FRAGMENT, IMMUNE SYSTEM 
4s1d:P     (ASP1) to   (ILE106)  STRUCTURE OF IGG1 FAB FRAGMENT IN COMPLEX WITH BIOTINCYTIDINAMIDE  |   ANTIBODY, FAB FRAGMENT, HAPTEN, MAB_M33_FAB_FRAGMENT, IMMUNE SYSTEM 
5gs2:D   (ASP127) to   (ILE232)  CRYSTAL STRUCTURE OF DIABODY COMPLEX WITH REPEBODY AND MBP  |   DIABODY, ANTIBODY FRAGMENT, COMPLEX, SUGAR BINDING PROTEIN-IMMUNE SYSTEM COMPLEX 
3dsf:L     (TYR1) to   (ILE106)  CRYSTAL STRUCTURE OF ANTI-OSTEOPONTIN ANTIBODY 23C3 IN COMPLEX WITH W43A MUTATED EPITOPE PEPTIDE  |   FAB, OSTEOPONTIN, OPN, ANTIBODY-ANTIGEN COMPLEX, IMMUNE SYSTEM 
3opz:M     (LEU3) to   (ILE105)  CRYSTAL STRUCTURE OF TRANS-SIALIDASE IN COMPLEX WITH THE FAB FRAGMENT OF A NEUTRALIZING MONOCLONAL IGG ANTIBODY  |   SIX-BLADED BETA-PROPELLER NEURAMINIDASE IMMUNOGLOBULIN DOMAIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX, HYDROLASE-IMMUNE SYSTEM COMPLEX 
3opz:N     (LEU3) to   (ILE105)  CRYSTAL STRUCTURE OF TRANS-SIALIDASE IN COMPLEX WITH THE FAB FRAGMENT OF A NEUTRALIZING MONOCLONAL IGG ANTIBODY  |   SIX-BLADED BETA-PROPELLER NEURAMINIDASE IMMUNOGLOBULIN DOMAIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX, HYDROLASE-IMMUNE SYSTEM COMPLEX 
4d9r:L     (ILE2) to   (ILE106)  INHIBITING ALTERNATIVE PATHWAY COMPLEMENT ACTIVATION BY TARGETING THE EXOSITE ON FACTOR D  |   FACTOR D, COMPLEMENT, ANTIBODY, EXOSITE, FAB, CHYMOTRYPSIN, PROTEASE, HYDROLASE-IMMUNE SYSTEM COMPLEX 
4d9r:D     (ILE2) to   (ILE106)  INHIBITING ALTERNATIVE PATHWAY COMPLEMENT ACTIVATION BY TARGETING THE EXOSITE ON FACTOR D  |   FACTOR D, COMPLEMENT, ANTIBODY, EXOSITE, FAB, CHYMOTRYPSIN, PROTEASE, HYDROLASE-IMMUNE SYSTEM COMPLEX 
3dvi:A     (ASP1) to   (ILE107)  CRYSTAL STRUCTURE OF KAPPA 1 AMYLOIDOGENIC LIGHT CHAIN VARIABLE DOMAIN  |   AL, LIGHT CHAIN AMYLOIDOSIS, AMYLOID, IMMUNOGLOBULIN, LIGHT CHAIN, LIGHT CHAIN VARIABLE DOMAIN, PROTEIN FIBRIL 
4dn3:L     (ILE2) to   (THR111)  CRYSTAL STRUCTURE OF ANTI-MCP-1 ANTIBODY CNTO888  |   ANTIBODY, IMMUNE SYSTEM 
5i1e:L     (GLN3) to   (THR109)  CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY IGHV3-53/IGKV1-39  |   MONOCLONAL ANTIBODY, IMMUNE SYSTEM 
5i8k:L     (ASP3) to   (VAL109)  HHH1 FAB FRAGMENT  |   ANTIBODY, GLYCAN BINDING, FAB, ALLERGY, IMMUNE SYSTEM 
5ies:L     (ASP1) to   (ILE106)  CRYSTAL STRUCTURE OF VRC01C-HUGL2 FAB FROM AN HIV-1 NAIVE DONOR IN COMPLEX WITH WITH A GERMLINE-TARGETING GP120 ENGINEERED OUTER DOMAIN EOD-GT8 AT 2.16 A  |   HIV-1 GP120, ENGINEERED OUTER DOMAIN (EOD), GERMLINE TARGETING, CD4 BINDING SITE, VRC01-CLASS NAIVE HUMAN GERMLINE ANTIBODY, IMMUNE SYSTEM, VIRAL-PROTEIN COMPLEX, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX, IMMUNE SYSTEM- VIRAL PROTEIN COMPLEX 
5if0:B     (ILE2) to   (ILE106)  CRYSTAL STRUCTURE OF VRC01C-HUGL2 FAB FROM AN HIV-1 NAIVE DONOR IN COMPLEX WITH WITH A GERMLINE-TARGETING GP120 ENGINEERED OUTER DOMAIN EOD-GT8 AT 2.44 A  |   HIV-1 GP120, ENGINEERED OUTER DOMAIN (EOD), GERMLINE TARGETING, CD4 BINDING SITE, VRC01-CLASS NAIVE HUMAN GERMLINE ANTIBODY, IMMUNE SYSTEM, VIRAL-PROTEIN COMPLEX, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX 
5itb:L     (ASP1) to   (ILE126)  CRYSTAL STRUCTURE OF THE ANTI-RSV F FAB 14N4  |   ANTIBODY, IMMUNE SYSTEM 
4ffz:L     (VAL3) to   (ILE106)  CRYSTAL STRUCTURE OF DENV1-E111 FAB FRAGMENT BOUND TO DENV-1 DIII (WESTERN PACIFIC-74 STRAIN).  |   STRUCTURAL GENOMICS, ANTIBODY FAB FRAGMENT, FLAVIVIRUS, DENGUE VIRUS, NIAID, NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES, CENTER FOR STRUCTURAL GENOMICS OF INFECTIOUS DISEASES, CSGID, IMMUNOGLOBULIN-LIKE DOMAIN, VIRAL ENVELOPE PROTEIN, VIRION, IMMUNE SYSTEM, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX 
4ffz:Y     (VAL3) to   (ILE106)  CRYSTAL STRUCTURE OF DENV1-E111 FAB FRAGMENT BOUND TO DENV-1 DIII (WESTERN PACIFIC-74 STRAIN).  |   STRUCTURAL GENOMICS, ANTIBODY FAB FRAGMENT, FLAVIVIRUS, DENGUE VIRUS, NIAID, NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES, CENTER FOR STRUCTURAL GENOMICS OF INFECTIOUS DISEASES, CSGID, IMMUNOGLOBULIN-LIKE DOMAIN, VIRAL ENVELOPE PROTEIN, VIRION, IMMUNE SYSTEM, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX 
4fnl:L     (ILE2) to   (THR109)  CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY C05  |   IMMUNOGLOBULIN, IMMUNE RECOGNITION, IMMUNE SYSTEM 
4fnl:M     (ILE2) to   (THR109)  CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY C05  |   IMMUNOGLOBULIN, IMMUNE RECOGNITION, IMMUNE SYSTEM 
4fp8:L     (ILE2) to   (THR109)  CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY C05 BOUND TO H3 INFLUENZA HEMAGGLUTININ, HA1 SUBUNIT  |   VIRAL FUSION PROTEIN, IMMUNOGLOBULIN, VIRUS ATTACHMENT AND ENTRY, IMMUNE RECOGNITION, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
4fp8:M     (ILE2) to   (THR109)  CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY C05 BOUND TO H3 INFLUENZA HEMAGGLUTININ, HA1 SUBUNIT  |   VIRAL FUSION PROTEIN, IMMUNOGLOBULIN, VIRUS ATTACHMENT AND ENTRY, IMMUNE RECOGNITION, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
4fp8:N     (ILE2) to   (THR109)  CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY C05 BOUND TO H3 INFLUENZA HEMAGGLUTININ, HA1 SUBUNIT  |   VIRAL FUSION PROTEIN, IMMUNOGLOBULIN, VIRUS ATTACHMENT AND ENTRY, IMMUNE RECOGNITION, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
4fp8:O     (ILE2) to   (THR109)  CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY C05 BOUND TO H3 INFLUENZA HEMAGGLUTININ, HA1 SUBUNIT  |   VIRAL FUSION PROTEIN, IMMUNOGLOBULIN, VIRUS ATTACHMENT AND ENTRY, IMMUNE RECOGNITION, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
4fqr:b     (ILE2) to   (ILE106)  CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY C05 BOUND TO H3 INFLUENZA HEMAGGLUTININ  |   VIRAL FUSION PROTEIN, IMMUNOGLOBULIN, VIRUS ATTACHMENT AND ENTRY, IMMUNE RECOGNITION, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
4fqr:d     (ILE2) to   (ILE106)  CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY C05 BOUND TO H3 INFLUENZA HEMAGGLUTININ  |   VIRAL FUSION PROTEIN, IMMUNOGLOBULIN, VIRUS ATTACHMENT AND ENTRY, IMMUNE RECOGNITION, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
4fqr:f     (ILE2) to   (ILE106)  CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY C05 BOUND TO H3 INFLUENZA HEMAGGLUTININ  |   VIRAL FUSION PROTEIN, IMMUNOGLOBULIN, VIRUS ATTACHMENT AND ENTRY, IMMUNE RECOGNITION, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
4fqr:h     (ILE2) to   (ILE106)  CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY C05 BOUND TO H3 INFLUENZA HEMAGGLUTININ  |   VIRAL FUSION PROTEIN, IMMUNOGLOBULIN, VIRUS ATTACHMENT AND ENTRY, IMMUNE RECOGNITION, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
4fqr:j     (ILE2) to   (ILE106)  CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY C05 BOUND TO H3 INFLUENZA HEMAGGLUTININ  |   VIRAL FUSION PROTEIN, IMMUNOGLOBULIN, VIRUS ATTACHMENT AND ENTRY, IMMUNE RECOGNITION, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
4fqr:l     (ILE2) to   (ILE106)  CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY C05 BOUND TO H3 INFLUENZA HEMAGGLUTININ  |   VIRAL FUSION PROTEIN, IMMUNOGLOBULIN, VIRUS ATTACHMENT AND ENTRY, IMMUNE RECOGNITION, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
4fqr:n     (ILE2) to   (ILE106)  CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY C05 BOUND TO H3 INFLUENZA HEMAGGLUTININ  |   VIRAL FUSION PROTEIN, IMMUNOGLOBULIN, VIRUS ATTACHMENT AND ENTRY, IMMUNE RECOGNITION, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
4fqr:p     (ILE2) to   (ILE106)  CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY C05 BOUND TO H3 INFLUENZA HEMAGGLUTININ  |   VIRAL FUSION PROTEIN, IMMUNOGLOBULIN, VIRUS ATTACHMENT AND ENTRY, IMMUNE RECOGNITION, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
4fqr:r     (ILE2) to   (ILE106)  CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY C05 BOUND TO H3 INFLUENZA HEMAGGLUTININ  |   VIRAL FUSION PROTEIN, IMMUNOGLOBULIN, VIRUS ATTACHMENT AND ENTRY, IMMUNE RECOGNITION, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
4fqr:t     (ILE2) to   (ILE106)  CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY C05 BOUND TO H3 INFLUENZA HEMAGGLUTININ  |   VIRAL FUSION PROTEIN, IMMUNOGLOBULIN, VIRUS ATTACHMENT AND ENTRY, IMMUNE RECOGNITION, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
4fqr:v     (ILE2) to   (THR109)  CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY C05 BOUND TO H3 INFLUENZA HEMAGGLUTININ  |   VIRAL FUSION PROTEIN, IMMUNOGLOBULIN, VIRUS ATTACHMENT AND ENTRY, IMMUNE RECOGNITION, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
4fqr:x     (ILE2) to   (ILE106)  CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY C05 BOUND TO H3 INFLUENZA HEMAGGLUTININ  |   VIRAL FUSION PROTEIN, IMMUNOGLOBULIN, VIRUS ATTACHMENT AND ENTRY, IMMUNE RECOGNITION, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
5jof:F     (GLU1) to   (VAL106)  CRYSTAL STRUCTURE OF VRC03 GHVGLV ANTIGEN-BINDING FRAGMENT.  |   HIV-1, CD4 BINDING SITE, NEUTRALIZING, ANTIBODY DEVELOPMENT, IMMUNE SYSTEM 
5sx4:L     (ASP1) to   (ILE106)  CRYSTAL STRUCTURE OF PANITUMUMAB IN COMPLEX WITH EPIDERMAL GROWTH FACTOR RECEPTOR DOMAIN 3.  |   CETUXIMAB, PANITUMUMAB, EGFR, VECTIBIX, ERBITUX, TRANSFERASE-IMMUNE SYSTEM COMPLEX 
5sx5:K     (ASP1) to   (ILE106)  CRYSTAL STRUCTURE OF PANITUMUMAB IN COMPLEX WITH EPIDERMAL GROWTH FACTOR RECEPTOR DOMAIN 3 MUTANT S468R.  |   CETUXIMAB, PANITUMUMAB, EGFR, VECTIBIX, ERBITUX, TRANSFERASE-IMMUNE SYSTEM COMPLEX 
5sx5:L     (ASP1) to   (ILE106)  CRYSTAL STRUCTURE OF PANITUMUMAB IN COMPLEX WITH EPIDERMAL GROWTH FACTOR RECEPTOR DOMAIN 3 MUTANT S468R.  |   CETUXIMAB, PANITUMUMAB, EGFR, VECTIBIX, ERBITUX, TRANSFERASE-IMMUNE SYSTEM COMPLEX 
5t5f:L     (ILE2) to   (ALA114)  NEISSERIA MENINGITIDIS FACTOR H BINDING PROTEIN IN COMPLEX WITH MONOCLONAL ANTIBODY JAR5  |   FHBP, JAR5, EPITOPE MAPPING, MONOCLONAL ANTIBODY, COOPERATIVITY, NEISSERIA MENINGITIDIS, PROTEIN BINDING 
1afv:L     (ILE2) to   (LEU110)  HIV-1 CAPSID PROTEIN (P24) COMPLEX WITH FAB25.3  |   COMPLEX (VIRAL CAPSID/IMMUNOGLOBULIN), HIV, CAPSID PROTEIN, P24, VIRAL PROTEIN/IMMUNE SYSTEM COMPLEX 
1afv:M     (ILE2) to   (LEU110)  HIV-1 CAPSID PROTEIN (P24) COMPLEX WITH FAB25.3  |   COMPLEX (VIRAL CAPSID/IMMUNOGLOBULIN), HIV, CAPSID PROTEIN, P24, VIRAL PROTEIN/IMMUNE SYSTEM COMPLEX 
1nlb:L     (ILE2) to   (ALA109)  CRYSTAL STRUCTURE OF ANTI-HCV MONOCLONAL ANTIBODY 19D9D6  |   MURINE MONOCLONAL ANTIBODY, IMMUNE SYSTEM 
4hg4:M     (ILE2) to   (ILE106)  CRYSTAL STRUCTURE OF FAB 2G1 IN COMPLEX WITH A H2N2 INFLUENZA VIRUS HEMAGGLUTININ  |   VIRAL PROTEIN/IMMUNE SYSTEM, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
4hg4:Q     (ASP1) to   (ILE106)  CRYSTAL STRUCTURE OF FAB 2G1 IN COMPLEX WITH A H2N2 INFLUENZA VIRUS HEMAGGLUTININ  |   VIRAL PROTEIN/IMMUNE SYSTEM, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
4hg4:Y     (ASP1) to   (ILE106)  CRYSTAL STRUCTURE OF FAB 2G1 IN COMPLEX WITH A H2N2 INFLUENZA VIRUS HEMAGGLUTININ  |   VIRAL PROTEIN/IMMUNE SYSTEM, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
3eyv:A     (GLN3) to   (ILE111)  ANTI-LEWIS Y FAB FRAGMENT WITH LEWIS Y ANTIGEN IN THE PRESENCE OF ZINC IONS  |   IMMUNOGLOBULIN FOLD, BETA BARREL, HUMANIZED ANTIBODY, ANTIGEN BINDING FRAGMENT, IMMUNE SYSTEM 
1bj1:L     (GLN3) to   (ILE106)  VASCULAR ENDOTHELIAL GROWTH FACTOR IN COMPLEX WITH A NEUTRALIZING ANTIBODY  |   COMPLEX (ANTIBODY/ANTIGEN), ANGIOGENIC FACTOR 
1bj1:J     (ILE2) to   (ILE106)  VASCULAR ENDOTHELIAL GROWTH FACTOR IN COMPLEX WITH A NEUTRALIZING ANTIBODY  |   COMPLEX (ANTIBODY/ANTIGEN), ANGIOGENIC FACTOR 
1cic:C     (GLN3) to   (ALA109)  IDIOTOPE-ANTI-IDIOTOPE FAB-FAB COMPLEX; D1.3-E225  |   IMMUNOGLOBULIN, FAB COMPLEX, IDIOTOPE, ANTI-IDIOTOPE 
1cz8:L     (ILE2) to   (THR109)  VASCULAR ENDOTHELIAL GROWTH FACTOR IN COMPLEX WITH AN AFFINITY MATURED ANTIBODY  |   COMPLEX (ANTIBODY/ANTIGEN), CYSTINE KNOT, FAB FRAGMENT, IMMUNE SYSTEM 
1cz8:X     (ILE2) to   (ILE106)  VASCULAR ENDOTHELIAL GROWTH FACTOR IN COMPLEX WITH AN AFFINITY MATURED ANTIBODY  |   COMPLEX (ANTIBODY/ANTIGEN), CYSTINE KNOT, FAB FRAGMENT, IMMUNE SYSTEM 
4jpw:L     (GLN3) to   (ILE106)  CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY 12A21 IN COMPLEX WITH HIV-1 STRAIN 93TH057 GP120 MUTANT  |   HIV, GP120, CD4-BINDING SITE, 12A21, NEUTRALIZATION, VACCINE, ANTIBODY, ENVELOPE PROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
4k07:B     (ILE2) to   (ILE106)  CRYSTAL STRUCTURE OF THE AMYLOID-FORMING IMMUNOGLOBULIN AL-103 CIS- PROLINE 95 MUTANT  |   IMMUNOGLOBULIN VARIABLE DOMAIN, AMYLOID PROTEIN, PATIENT-DERIVED SEQUENCE, IMMUNE SYSTEM 
4k07:C     (THR0) to   (ILE106)  CRYSTAL STRUCTURE OF THE AMYLOID-FORMING IMMUNOGLOBULIN AL-103 CIS- PROLINE 95 MUTANT  |   IMMUNOGLOBULIN VARIABLE DOMAIN, AMYLOID PROTEIN, PATIENT-DERIVED SEQUENCE, IMMUNE SYSTEM 
4k8r:C     (ALA2) to   (ILE107)  AN ANTIBODY AGAINST THE C-TERMINAL DOMAIN OF PCSK9 LOWERS LDL CHOLESTEROL LEVELS IN VIVO  |   IMMUNOGLOBULIN, IMMUNE SYSTEM 
1fve:A     (ILE2) to   (ILE106)  X-RAY STRUCTURES OF THE ANTIGEN-BINDING DOMAINS FROM THREE VARIANTS OF HUMANIZED ANTI-P185-HER2 ANTIBODY 4D5 AND COMPARISON WITH MOLECULAR MODELING  |   IMMUNOGLOBULIN 
2vdm:L     (ILE2) to   (ILE106)  RE-REFINEMENT OF INTEGRIN ALPHAIIBBETA3 HEADPIECE BOUND TO ANTAGONIST TIROFIBAN  |   CELL ADHESION-IMMUNE SYSTEM COMPLEX, FIBRINOGEN BINDING, PLATELET INTEGRIN ALPHAIIBBETA3, GLYCOPROTEIN, CELL ADHESION, MEMBRANE, INTEGRIN, RECEPTOR, ANTAGONIST, HOST-VIRUS INTERACTION, PYRROLIDONE CARBOXYLIC ACID, TRANSMEMBRANE, PHOSPHORYLATION, DISEASE MUTATION, CLEAVAGE ON PAIR OF BASIC RESIDUES, CELL ADHESION/IMMUNE SYSTEM COMPLEX 
4ki5:F     (GLN3) to   (ILE106)  CYSTAL STRUCTURE OF HUMAN FACTOR VIII C2 DOMAIN IN A TERNARY COMPLEX WITH MURINE INHBITORY ANTIBODIES 3E6 AND G99  |   IMMUNOGLOBULIN FOLD, DISCOIDIN FOLD, ANTIBODY, BLOOD COAGULATION FACTOR, ANTIGEN BINDING, BLOOD PLASMA, IMMUNE SYSTEM 
1gc1:L     (GLU1) to   (ILE108)  HIV-1 GP120 CORE COMPLEXED WITH CD4 AND A NEUTRALIZING HUMAN ANTIBODY  |   COMPLEX (HIV ENVELOPE PROTEIN-CD4-FAB), HIV-1 EXTERIOR ENVELOPE GP120, T-CELL SURFACE GLYCOPROTEIN CD4, ANTIGEN-BINDING FRAGMENT OF HUMAN IMMUNOGLOBULIN 17B, GLYCOSYLATED PROTEIN, VIRAL PROTEIN- RECEPTOR-IMMUNE SYSTEM COMPLEX 
1ghf:L     (ASP1) to   (ILE106)  ANTI-ANTI-IDIOTYPE GH1002 FAB FRAGMENT  |   ANTIBODY FAB FRAGMENT 
3v0w:L     (ASP1) to   (ILE106)  CRYSTAL STRUCTURE OF FAB WN1 222-5 IN COMPLEX WITH LPS  |   BETA BARREL, ANTIBODY, FAB, IMMUNE SYSTEM 
4kq3:L     (GLN3) to   (THR108)  CRYSTAL STRUCTURE OF ANTI-IL-17A ANTIBODY CNTO3186  |   IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM 
4kxz:I     (THR2) to   (ILE107)  CRYSTAL STRUCTURE OF TGFB2 IN COMPLEX WITH GC2008.  |   CYSTEINE KNOT, FAB, VARIOUS GROWTH FUNCTIONS (TGF-BETA), TGF-BETA ANTAGONIST (GC2008), TGF-BETA RECEPTORS, IMMUNE SYSTEM 
4kxz:L     (THR2) to   (ILE107)  CRYSTAL STRUCTURE OF TGFB2 IN COMPLEX WITH GC2008.  |   CYSTEINE KNOT, FAB, VARIOUS GROWTH FUNCTIONS (TGF-BETA), TGF-BETA ANTAGONIST (GC2008), TGF-BETA RECEPTORS, IMMUNE SYSTEM 
4kxz:M     (THR2) to   (ILE107)  CRYSTAL STRUCTURE OF TGFB2 IN COMPLEX WITH GC2008.  |   CYSTEINE KNOT, FAB, VARIOUS GROWTH FUNCTIONS (TGF-BETA), TGF-BETA ANTAGONIST (GC2008), TGF-BETA RECEPTORS, IMMUNE SYSTEM 
4kxz:P     (THR2) to   (ILE107)  CRYSTAL STRUCTURE OF TGFB2 IN COMPLEX WITH GC2008.  |   CYSTEINE KNOT, FAB, VARIOUS GROWTH FUNCTIONS (TGF-BETA), TGF-BETA ANTAGONIST (GC2008), TGF-BETA RECEPTORS, IMMUNE SYSTEM 
4zpv:L     (ILE2) to   (ALA109)  STRUCTURE OF MERS-CORONAVIRUS SPIKE RECEPTOR-BINDING DOMAIN (ENGLAND1 STRAIN) IN COMPLEX WITH VACCINE-ELICITED MURINE NEUTRALIZING ANTIBODY D12 (CRYSTAL FORM 2)  |   VACCINE, IMMUNOGEN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
3wii:L     (ASP1) to   (LEU106)  CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF B2212A, A MURINE MONOCLONAL ANTIBODY SPECIFIC FOR THE THIRD FIBRONECTIN DOMAIN (FN3) OF HUMAN ROBO1.  |   IMMUNOGLOBULIN FAB FRAGMENT, ANTI-HEPATOCELLULAR CARCINOMA ANTIBODY, THE THIRD FIBRONECTIN TYPE-III DOMAIN (FN3) OF HUMAN ROBO1, IMMUNE SYSTEM 
5chn:B     (ILE2) to   (ILE112)  FAB FRAGMENTS OF CHIKUNGUNYA VIRUS NEUTRALIZING HUMAN MONOCLONAL ANTIBODY 5M16  |   ANTIBODY, IMMUNE SYSTEM 
2zck:L     (VAL3) to   (ILE106)  CRYSTAL STRUCTURE OF A TERNARY COMPLEX BETWEEN PSA, A SUBSTRAT-ACYL INTERMEDIATE AND AN ACTIVATING ANTIBODY  |   HUMAN PSA, ANTIBODIES, KALLIKREIN RELATED PEPTIDASES, PROSTATE CANCER, GLYCOPROTEIN, HYDROLASE, PROTEASE, SECRETED, SERINE PROTEASE, ZYMOGEN, IMMUNE SYSTEM 
1y18:L     (GLU1) to   (ILE106)  FAB FRAGMENT OF CATALYTIC ELIMINATION ANTIBODY 34E4 E(H50)D MUTANT IN COMPLEX WITH HAPTEN  |   IMMUNOGLOBULIN, CATALYTIC ANTIBODY, CHIMERIC FAB, HAPTEN COMPLEX, IMMUNE SYSTEM 
1y18:A     (LEU2) to   (ILE106)  FAB FRAGMENT OF CATALYTIC ELIMINATION ANTIBODY 34E4 E(H50)D MUTANT IN COMPLEX WITH HAPTEN  |   IMMUNOGLOBULIN, CATALYTIC ANTIBODY, CHIMERIC FAB, HAPTEN COMPLEX, IMMUNE SYSTEM 
1y18:C     (LEU2) to   (ILE106)  FAB FRAGMENT OF CATALYTIC ELIMINATION ANTIBODY 34E4 E(H50)D MUTANT IN COMPLEX WITH HAPTEN  |   IMMUNOGLOBULIN, CATALYTIC ANTIBODY, CHIMERIC FAB, HAPTEN COMPLEX, IMMUNE SYSTEM 
1y18:E     (GLU1) to   (ILE106)  FAB FRAGMENT OF CATALYTIC ELIMINATION ANTIBODY 34E4 E(H50)D MUTANT IN COMPLEX WITH HAPTEN  |   IMMUNOGLOBULIN, CATALYTIC ANTIBODY, CHIMERIC FAB, HAPTEN COMPLEX, IMMUNE SYSTEM 
1mfe:L     (PCA1) to   (LEU109)  RECOGNITION OF A CELL-SURFACE OLIGO-SACCHARIDE OF PATHOGENIC SALMONELLA BY AN ANTIBODY FAB FRAGMENT  |   IMMUNOGLOBULIN 
1ymh:C     (VAL3) to   (LEU106)  ANTI-HCV FAB 19D9D6 COMPLEXED WITH PROTEIN L (PPL) MUTANT A66W  |   ENGINEERING OF CRYSTAL CONTACTS, PPL-FAB COMPLEX, IMMUNE SYSTEM 
3bdy:L     (ASP1) to   (ILE106)  DUAL SPECIFIC BH1 FAB IN COMPLEX WITH VEGF  |   FAB COMPLEX, ANGIOGENESIS, DEVELOPMENTAL PROTEIN, DIFFERENTIATION, GLYCOPROTEIN, GROWTH FACTOR, HEPARIN-BINDING, MITOGEN, SECRETED, HORMONE 
4qxt:B     (ASP1) to   (ILE110)  CRYSTAL STRUCTURE OF ANTI-MSP2 FV FRAGMENT (MAB6D8)IN COMPLEX WITH FC27-MSP2 14-30  |   IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM, N-TERMINAL MSP2, UNSTRUCTURED ANTIGEN 
4qyo:B     (ASP1) to   (ILE110)  CRYSTAL STRUCTURE OF ANTI-MSP2 FV FRAGMENT (MAB6D8)IN COMPLEX WITH MSP2 14-22  |   IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM, N-TERMINAL MSP2, UNSTRUCTURED ANTIGEN 
3c09:L     (ASP1) to   (THR108)  CRYSTAL STRUCTURE THE FAB FRAGMENT OF MATUZUMAB (FAB72000) IN COMPLEX WITH DOMAIN III OF THE EXTRACELLULAR REGION OF EGFR  |   CELL SURFACE RECEPTOR, GLYCOPROTEIN, ANTIGEN, ANTIBODY COMPLEX, FAB FRAGMENT, ANTITUMOR, DRUG IMMUNE SYSTEM-TRANSFERASE COMPLEX, IMMUNE SYSTEM-TRANSFERASE COMPLEX 
3c09:B     (ASP1) to   (ILE105)  CRYSTAL STRUCTURE THE FAB FRAGMENT OF MATUZUMAB (FAB72000) IN COMPLEX WITH DOMAIN III OF THE EXTRACELLULAR REGION OF EGFR  |   CELL SURFACE RECEPTOR, GLYCOPROTEIN, ANTIGEN, ANTIBODY COMPLEX, FAB FRAGMENT, ANTITUMOR, DRUG IMMUNE SYSTEM-TRANSFERASE COMPLEX, IMMUNE SYSTEM-TRANSFERASE COMPLEX 
5fb8:A    (ASP26) to   (THR138)  STRUCTURE OF INTERLEUKIN-16 BOUND TO THE 14.1 ANTIBODY  |   CYTOKINE, INTERLEUKIN, ANTIBODY, COMPLEX, IMMUNE SYSTEM 
5fec:L     (GLN3) to   (ILE102)  CRYSTAL STRUCTURE OF 3BNC60 FAB GERMLINE PRECURSOR IN COMPLEX WITH 426C.TM4DELTAV1-3 GP120  |   ANTIBODY, IMMUNE SYSTEM, HIV-1 
5fec:B     (ASP1) to   (ILE102)  CRYSTAL STRUCTURE OF 3BNC60 FAB GERMLINE PRECURSOR IN COMPLEX WITH 426C.TM4DELTAV1-3 GP120  |   ANTIBODY, IMMUNE SYSTEM, HIV-1 
3nzh:L     (ILE2) to   (ILE106)  CRYSTAL STRUCTURE OF ANTI-EMMPRIN ANTIBODY 5F6 FAB  |   IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM 
5grw:A   (VAL126) to   (GLU229)  CRYSTAL STRUCTURE OF HOMO-SPECIFIC DIABODY  |   DIABODY, ANTIBODY FRAGMENT, IMMUNE SYSTEM 
4d9q:D     (ILE2) to   (ILE106)  INHIBITING ALTERNATIVE PATHWAY COMPLEMENT ACTIVATION BY TARGETING THE EXOSITE ON FACTOR D  |   FACTOR D, COMPLEMENT, ANTIBODY, EXOSITE, FAB, CHYMOTRYPSIN, PROTEASE, HYDROLASE-IMMUNE SYSTEM COMPLEX 
5i1a:L     (ILE2) to   (ILE106)  CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY IGHV3-23/IGKV3-11  |   MONOCLONAL ANTIBODY, IMMUNE SYSTEM 
5i1a:A     (ILE2) to   (THR109)  CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY IGHV3-23/IGKV3-11  |   MONOCLONAL ANTIBODY, IMMUNE SYSTEM 
4g7y:L     (ILE2) to   (ILE106)  CRYSTAL STRUCTURE OF VOLTAGE SENSING DOMAIN OF CI-VSP WITH FRAGMENT ANTIBODY (R217E, 2.8 A)  |   MEMBRANE PROTEIN, ALPHA HELIX, FRAGMENT ANTIBODY, VOLTAGE SENSING DOMAIN, SENSING VOLTAGE 
4g80:B     (ILE2) to   (THR109)  CRYSTAL STRUCTURE OF VOLTAGE SENSING DOMAIN OF CI-VSP WITH FRAGMENT ANTIBODY (WT, 3.8 A)  |   MEMBRANE PROTEIN, ALPHA HELIX, FRAGMENT ANTIBODY, VOLTAGE SENSING DOMAIN, SENSING VOLTAGE 
4g80:D     (ILE2) to   (ILE106)  CRYSTAL STRUCTURE OF VOLTAGE SENSING DOMAIN OF CI-VSP WITH FRAGMENT ANTIBODY (WT, 3.8 A)  |   MEMBRANE PROTEIN, ALPHA HELIX, FRAGMENT ANTIBODY, VOLTAGE SENSING DOMAIN, SENSING VOLTAGE 
4g80:F     (ILE2) to   (ILE106)  CRYSTAL STRUCTURE OF VOLTAGE SENSING DOMAIN OF CI-VSP WITH FRAGMENT ANTIBODY (WT, 3.8 A)  |   MEMBRANE PROTEIN, ALPHA HELIX, FRAGMENT ANTIBODY, VOLTAGE SENSING DOMAIN, SENSING VOLTAGE 
4g80:H     (ILE2) to   (ILE106)  CRYSTAL STRUCTURE OF VOLTAGE SENSING DOMAIN OF CI-VSP WITH FRAGMENT ANTIBODY (WT, 3.8 A)  |   MEMBRANE PROTEIN, ALPHA HELIX, FRAGMENT ANTIBODY, VOLTAGE SENSING DOMAIN, SENSING VOLTAGE